40
Participants
Start Date
September 30, 1997
Primary Completion Date
April 30, 2000
alvocidib
Michiana Hematology/Oncology P.C., South Bend
Lutheran General Hospital, Park Ridge
Evanston Northwestern Health Care, Evanston
Clinical Sciences Building, Chicago
University of Chicago Cancer Research Center, Chicago
Louis A. Weiss Memorial Hospital, Chicago
Oncology/Hematology Associates of Central Illinois, P.C., Peoria
Cancer Care Specialists of Central Illinois, S.C., Decatur
Central Illinois Hematology Oncology Center, Springfield
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
National Cancer Institute (NCI)
NIH